指南与共识呼吸道感染呼吸危重症与机械通气

2017年欧洲指南经验性治疗建议对医院获得性肺炎的影响

Impact of Empirical Treatment Recommendations From 2017 European Guidelines for Nosocomial Pneumonia.
指南 / 共识 · Chest · 2024-10-24

该研究基于6个ICU的前瞻性队列,回顾性分析315例微生物学确诊的医院获得性肺炎患者,评估2017年欧洲指南经验性抗菌治疗算法的有效性。结果显示,遵循指南与否总体结局相当,但遵循指南时过度治疗更高(42.5% vs 66.3%;P < .001);在无感染性休克亚组中,遵循指南可降低ICU死亡率(28.8% vs 14.5%;P = .031)并改善调整28天死亡率(HR, 3.07;95% CI, 1.13-7.85;P = .027),而感染性休克患者未见获益。

要点

  • 遵循2017年欧洲指南经验性治疗算法在无感染性休克患者中可降低死亡率。
  • 感染性休克患者遵循指南未见生存获益,需进一步研究调整策略。
  • 遵循指南与更高的过度治疗发生率相关(66.3% vs 42.5%;P < .001)。

核心结论

  • 欧洲指南治疗算法在无感染性休克患者中有效降低死亡率,但在诊断时存在感染性休克的患者中无效。

研究设计与样本

  • 回顾性分析6个ICU的前瞻性队列,共507例患者,仅纳入微生物学确诊肺炎者315例。

主要发现

  • 遵循与不遵循指南组总体结局相当,但遵循指南组过度治疗更高(42.5% vs 66.3%;P < .001)。
  • 无感染性休克亚组遵循指南者ICU死亡率降低(28.8% vs 14.5%;P = .031)。
  • 无感染性休克亚组遵循指南者调整28天死亡率改善(HR, 3.07;95% CI, 1.13-7.85;P = .027)。
  • 感染性休克患者遵循指南未见获益。

临床怎么用

  • 对无感染性休克的医院获得性肺炎患者,可考虑遵循2017年欧洲指南经验性治疗算法以降低死亡率。
  • 对诊断时存在感染性休克的患者,遵循该算法未见获益,需个体化评估。

局限性

  • 回顾性分析设计。
  • 仅纳入微生物学确诊肺炎患者,可能限制外推性。
  • 单中心研究,来自6个ICU。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The management of nosocomial pneumonia represents a major challenge in the ICU. European guidelines from 2017 proposed an algorithm for the prescription of empirical antimicrobial treatment based on medical history, local ecology, and severity (ie, presence or absence of septic shock). We assessed this algorithm's usefulness by comparing outcomes with and without guideline adherence in a population at high risk of multiresistance and mortality. RESEARCH QUESTION: Are the recommendations of the latest European guidelines effective in reducing the incidence of adverse outcomes in patients with nosocomial pneumonia admitted to the ICU? STUDY DESIGN AND METHODS: We retrospectively analyzed data from a prospective cohort of 507 patients from 6 ICUs in our center. To minimize bias, we only included patients with microbiologically confirmed pneumonia. The primary outcome was 28-day mortality. Secondary outcomes were 90-day mortality, ICU mortality, inadequate treatment, treatment failure, and overtreatment. RESULTS: In total, 315 patients met the inclusion criteria. Outcomes were comparable in the groups with and without guideline adherence, except for overtreatment, which was higher when guidelines were followed (42.5% vs 66.3%; P < .001). In the subgroup without septic shock treated according to guidelines, reductions were noted in both ICU mortality (28.8% vs 14.5%; P = .031) and adjusted 28-day mortality (hazard ratio, 3.07; 95% CI, 1.13-7.85; P = .027). By contrast, no benefit was observed when patients presented with septic shock at diagnosis. INTERPRETATION: Our findings indicate that the European guideline treatment algorithm is effective in reducing mortality in patients without septic shock but not in those with septic shock at the time of diagnosis. Future studies should clarify whether adjustments need to be made to improve outcomes in patients with septic shock.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Calabretta, Cilloniz, Gabarrus, et al. Impact of Empirical Treatment Recommendations From 2017 European Guidelines for Nosocomial Pneumonia. Chest. 2024. PMID: 39461555. doi:10.1016/j.chest.2024.10.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。